A reinforced random walk model of tumour angiogenesis and anti-angiogenic strategies
- PMID: 14636027
- DOI: 10.1093/imammb/20.2.135
A reinforced random walk model of tumour angiogenesis and anti-angiogenic strategies
Abstract
It is now well accepted that the growth of a tumour beyond approximately 2 mm in diameter is dependent on its ability to induce the growth of new blood vessels, a process called angiogenesis. This has raised hope that an anti-angiogenic treatment may be effective in the fight against cancer. Here we formulate, using the theory of reinforced random walks, an individual cell-based mathematical model of tumour angiogenesis in response to a diffusible angiogenic factor. The early stages of angiogenesis, in which endothelial cells (EC) escape the parent vessel and invade the extra-cellular matrix, are included in the model, as are the action of a proteolytic enzyme, EC proliferation and capillary branching and anastomosis. The anti-angiogenic potential of angiostatin, a known inhibitor of angiogenesis, is also examined. The capillary networks predicted by the model are in qualitative agreement with experimental observations. Proteolysis and proliferation are shown to be crucial for vascularization, whilst angiostatin is seen to be capable of limiting capillary growth.
Similar articles
-
Mathematical modeling of capillary formation and development in tumor angiogenesis: penetration into the stroma.Bull Math Biol. 2001 Sep;63(5):801-63. doi: 10.1006/bulm.2001.0240. Bull Math Biol. 2001. PMID: 11565406
-
The role of the angiopoietins in tumour angiogenesis.Growth Factors. 2004 Mar;22(1):1-11. doi: 10.1080/08977190310001643218. Growth Factors. 2004. PMID: 15179939 Review.
-
Numerical simulation of the inhibitory effect of angiostatin on metastatic tumor angiogenesis and microenvironment.Bull Math Biol. 2013 Feb;75(2):274-87. doi: 10.1007/s11538-012-9805-2. Epub 2013 Jan 5. Bull Math Biol. 2013. PMID: 23292363
-
Simulation of tumor-induced angiogenesis and its response to anti-angiogenic drug treatment: mode of drug delivery and clearance rate dependencies.J Cancer Res Clin Oncol. 2004 Jan;130(1):15-24. doi: 10.1007/s00432-003-0491-1. Epub 2003 Oct 28. J Cancer Res Clin Oncol. 2004. PMID: 14586644
-
Angiogenesis inhibitors and the need for anti-angiogenic therapeutics.J Dent Res. 2007 Oct;86(10):927-36. doi: 10.1177/154405910708601005. J Dent Res. 2007. PMID: 17890668 Review.
Cited by
-
Integration of quantitative methods and mathematical approaches for the modeling of cancer cell proliferation dynamics.Am J Physiol Cell Physiol. 2023 Feb 1;324(2):C247-C262. doi: 10.1152/ajpcell.00185.2022. Epub 2022 Dec 12. Am J Physiol Cell Physiol. 2023. PMID: 36503241 Free PMC article. Review.
-
Reinforced diffusions as models of memory-mediated animal movement.J R Soc Interface. 2023 Mar;20(200):20220700. doi: 10.1098/rsif.2022.0700. Epub 2023 Mar 29. J R Soc Interface. 2023. PMID: 36987616 Free PMC article.
-
Cell-oriented modeling of angiogenesis.ScientificWorldJournal. 2011;11:1735-48. doi: 10.1100/2011/586475. Epub 2011 Oct 18. ScientificWorldJournal. 2011. PMID: 22125432 Free PMC article. Review.
-
A hybrid model of the role of VEGF binding in endothelial cell migration and capillary formation.Front Oncol. 2013 May 10;3:102. doi: 10.3389/fonc.2013.00102. eCollection 2013. Front Oncol. 2013. PMID: 23675570 Free PMC article.
-
A systems biology view of blood vessel growth and remodelling.J Cell Mol Med. 2014 Aug;18(8):1491-508. doi: 10.1111/jcmm.12164. Epub 2013 Nov 17. J Cell Mol Med. 2014. PMID: 24237862 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
